GSE120259 Engineered adoptive T cell therapy prolongs survival in a preclinical model of advanced stage ovarian cancer [Human]

Conclusions: Treatment with engineered T cells may have clinical applicability in patients with advanced-stage HGSOC.
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by array Homo sapiens Source Type: research